You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

upadacitinib

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)

Not yet recruiting
  • Juvenile Idiopathic Arthritis
  • (no location specified)
Nov 7, 2022

Atopic Dermatitis (AD) Trial (Upadacitinib)

No longer available
  • Atopic Dermatitis (AD)
  • Upadacitinib
  • (no location specified)
Aug 2, 2021

Atopic Dermatitis (AD) Trial (Upadacitinib, Placebo for Upadacitinib)

Withdrawn
  • Atopic Dermatitis (AD)
  • Upadacitinib
  • Placebo for Upadacitinib
  • (no location specified)
Apr 7, 2021

Hidradenitis Suppurativa (HS) Trial in Worldwide (Upadacitinib, Placebo Upadacitinib)

Completed
  • Hidradenitis Suppurativa (HS)
  • Upadacitinib
  • Placebo Upadacitinib
  • Phoenix, Arizona
  • +25 more
Mar 22, 2022

Rheumatoid Arthritis Trial (Upadacitinib, Adalimumab)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Nov 29, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
Has Results
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)

Recruiting
  • Takayasu Arteritis (TAK)
  • Upadacitinib
  • +2 more
  • Salvador, Bahia, Brazil
  • +44 more
Aug 22, 2022

Atopic Dermatitis Trial in Japan (Upadacitinib, Placebo for upadacitinib, Topical Corticosteroids (TCS))

Active, not recruiting
  • Atopic Dermatitis
  • Upadacitinib
  • +2 more
  • Ichinomiya-shi, Aichi, Japan
  • +42 more
Dec 1, 2021

Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)

Not yet recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Upadacitinib
  • +5 more
  • Birmingham, Alabama
  • +1 more
Oct 18, 2021

Assess Disease Activity in Adult Ankylosing Spondylitis Who

Recruiting
  • Radiographic Axial Spondylarthritis (r-axSpA)
  • Upadacitinib
  • Ulm, Baden-Wuerttemberg, Germany
  • +69 more
Aug 8, 2022

Rheumatoid Arthritis (RA) Trial in Brazil, China, Korea, Republic of (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Upadacitinib
  • Placebo
  • Curitiba, Parana, Brazil
  • +42 more
Aug 30, 2021

Atopic Dermatitis Trial in Worldwide (Upadacitinib, Placebo)

Completed
Has Results
  • Atopic Dermatitis
  • Upadacitinib
  • Placebo
  • Tampa, Florida
  • +33 more
Jul 1, 2020

Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)

Active, not recruiting
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +152 more
Jul 27, 2022

Atopic Dermatitis Trial in Worldwide (Upadacitinib)

Not yet recruiting
  • Atopic Dermatitis
  • Upadacitinib
  • Kogarah, New South Wales, Australia
  • +136 more
Aug 18, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo
  • Upadacitinib
  • Hemet, California
  • +62 more
Jul 28, 2021

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Completed
Has Results
  • Rheumatoid Arthritis (RA)
  • Huntsville, Alabama
  • +114 more
Apr 6, 2021

Atopic Dermatitis Trial in Worldwide (Placebo for Upadacitinib, Upadacitinib)

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Placebo for Upadacitinib
  • Upadacitinib
  • Birmingham, Alabama
  • +195 more
Mar 1, 2022

Atopic Dermatitis Trial in Worldwide (Placebo, Upadacitinib, Topical corticosteroids (TCS))

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +189 more
Mar 8, 2022

Psoriatic Arthritis Trial in Worldwide (Adalimumab, Upadacitinib, Placebo to Upadacitinib)

Active, not recruiting
Has Results
  • Psoriatic Arthritis
  • Huntsville, Alabama
  • +344 more
Dec 27, 2021

Atopic Dermatitis Trial in Worldwide (Placebo for Upadacitinib, Upadacitinib)

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Placebo for Upadacitinib
  • Upadacitinib
  • Phoenix, Arizona
  • +179 more
Feb 2, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Upadacitinib
  • Placebo
  • Huntsville, Alabama
  • +187 more
Feb 14, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo
  • Upadacitinib
  • Mesa, Arizona
  • +166 more
Mar 17, 2022

Atopic Dermatitis Trial in Worldwide (Upadacitinib, Dupilumab)

Recruiting
  • Atopic Dermatitis
  • Phoenix, Arizona
  • +297 more
Feb 1, 2023

Giant Cell Arteritis (GCA) Trial in Worldwide (Upadacitinib, Corticosteroid (CS), Placebo)

Recruiting
  • Giant Cell Arteritis (GCA)
  • Upadacitinib
  • +2 more
  • Huntsville, Alabama
  • +173 more
Aug 23, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

Active, not recruiting
Has Results
  • Rheumatoid Arthritis
  • Placebo for Adalimumab
  • +3 more
  • Birmingham, Alabama
  • +369 more
Jun 14, 2022